Arava and Levemir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arava (leflunomide) and Levemir (insulin detemir recombinant). Common drug interactions include abdominal pain among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Arava and Levemir. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,040 Arava users. Check the latest studies of Arava.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.



On Jul, 10, 2026

24 people who take Arava and Levemir together, and have interactions are studied.

Arava and Levemir drug interactions.

What are the common drug interactions of Arava and Levemir, by gender? *:

female:

  1. Abdominal pain
  2. Abdominal mass (localized enlargement or swelling in the human abdomen)
  3. Carbohydrate antigen 125 increased
  4. Dizziness
  5. Haemoglobin decreased
  6. Urinary tract infection
  7. Abdominal wall abscess (abdominal wall infection)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Chest pain
  10. Cholecystitis (infection of gallbladder)

male:

  1. Arthralgia (joint pain)
  2. Oedema peripheral (superficial swelling)
  3. Carbohydrate metabolism disorder (inability of carbohydrate metabolism)
  4. Confusional state
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Decreased interest
  7. Depressed mood
  8. Diabetes mellitus inadequate control
  9. Dysarthria (speech disorder)
  10. Dyspepsia (indigestion)

What are the common drug interactions of Arava and Levemir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Aggression
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Anger
  4. Anxiety
  5. Apallic syndrome (serious brain damage, when cortical parts of the brain are disconnected from brainstem)
  6. Arthralgia (joint pain)
  7. Arthropathy
  8. Asthenia (weakness)
  9. Body temperature increased
  10. Carbohydrate metabolism disorder (inability of carbohydrate metabolism)

50-59:

  1. Arthralgia (joint pain)
  2. Oedema peripheral (superficial swelling)
  3. Abdominal pain
  4. Abdominal wall abscess (abdominal wall infection)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chest pain
  7. Groin abscess (pus in groin)
  8. Peripheral swelling
  9. Subcutaneous abscess
  10. Urinary tract infection

60+:

  1. Arthralgia (joint pain)
  2. Chondropathy (disease of the cartilage)
  3. Delirium (wild excitement)
  4. Diarrhoea
  5. General physical condition
  6. Hepatitis a
  7. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  8. Hypoglycaemic unconsciousness (unconsciousness due to low blood sugar)
  9. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  10. Infection

What are the existing conditions these people have? *

  1. Pain: 6 people, 25.00%
  2. High Blood Pressure: 5 people, 20.83%
  3. High Blood Cholesterol: 4 people, 16.67%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.67%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 12.50%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
  7. Type 1 Diabetes: 2 people, 8.33%
  8. Asthma: 2 people, 8.33%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 8.33%
  10. Dizziness: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Arava and Levemir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arava and Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levemir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide and insulin detemir recombinant (the active ingredients of Arava and Levemir, respectively), and Arava and Levemir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: